Your Partners In Drug Development And Safety

Ergomed is a global leader in clinical research, offering specialized drug development solutions across oncology, rare diseases, and pharmacovigilance. With over 25 years of experience and more than 1,800 trials conducted, Ergomed provides full-service Phase I-IV trial management, regulatory support, and patient recruitment expertise.

Their strong oncology heritage includes over 470 oncology studies, leveraging innovative site management and study physician models to accelerate patient enrollment and ensure data quality. In rare diseases, Ergomed’s patient-centric approach and advocacy partnerships maximize recruitment success, having supported 350+ rare disease trials across 125 unique indications. With a global presence and specialized expertise, Ergomed is the ideal partner for biopharmaceutical companies seeking efficient, high-quality clinical trial execution.